SCHEMBL13074145

SCHEMBL13074145

CCN1CCC2(CC1)OCCN2CC

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 1/20 0.40
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
HTR2B P41595 1/20 0.32
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13074144 0.89 KDM4E (0.36) ACKR3KDM4EGAAHTR2B
SCHEMBL19069550 0.79
SCHEMBL12656380 0.78 TSHR (0.33) TSHR
SCHEMBL12656146 0.78 ACKR3 (0.30) ACKR3TSHR
SCHEMBL21730415 0.78
SCHEMBL21730453 0.76
SCHEMBL21619466 0.73
SCHEMBL22381235 0.72
SCHEMBL21620153 0.72
SCHEMBL19069642 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100280057-A1 NOVEL ANALGESIC THAT BINDS FILAMIN A BURNS BARBIER LINDSAY 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280057-A1 NOVEL ANALGESIC THAT BINDS FILAMIN A FLNA, OPRL1, FLNB ACKR3 813/4885KDM4E 4311/4885GAA 4716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.